- Home
- Companies
- Streck, Inc.
- Products
- Streck - Model Cell-Free DNA BCT - ...
Streck - Model Cell-Free DNA BCT - Direct-Draw Venous Whole Blood Collection Device
Cell-Free DNA BCT is a direct-draw venous whole blood collection device intended for the collection, stabilization and transport of venous whole blood samples for use in conjunction with cell-free DNA next generation sequencing liquid biopsy assays that have been cleared or approved for use with samples collected in the Cell-Free DNA BCT device.
Cell-Free DNA BCT is a direct-draw venous whole blood collection device intended for the collection, stabilization and transport of venous whole blood samples for use in conjunction with cell-free DNA next generation sequencing liquid biopsy assays that have been cleared or approved for use with samples collected in the Cell-Free DNA BCT device.
Accurate analysis of cell-free DNA can be compromised by sample handling, shipping and processing, causing lysis of nucleated blood cells and subsequent release of cellular genomic DNA. The preservative reagent contained in Cell-Free DNA BCT reduces the release of cellular genomic DNA. This claim has been substantiated compared to cfDNA isolated from K2EDTA tubes for liquid biopsy next-generation sequencing assays. The blood collection tube is intended for the preservation of cell-free DNA.
Performance characteristics of this device have only been established on the Guardant360 CDx assay.